Skip to content

effect of rosemary on the control of rheumatoid arthritis

The effect of rosemary leaf powder on disease activity, inflammatory and oxidative factors in adult people with rheumatoid arthritis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120415009472N24
Enrollment
72
Registered
2022-02-26
Start date
2021-10-23
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis. Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention 1: Intervention group: Receive twice a day, 2 grams of rosemary powder sachet made by Green Plants of Life Company as an additive to yogurt, buttermilk and food for 3 months. Intervention

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of Rheumatoid Arthritis Based on American College of Rheumatology (ACR) Criteria (If there are at least four criteria for six weeks of the criteria 1- Morning dryness for at least one hour in three joints or more 2- Arthritis of three joint areas or more 3- Arthritis of the hand joints 4- Symmetric arthritis 5- Rheumatoid nodules 6- Positive rheumatoid factor 7- Typical radiographic changes in the wrist and hand) The patient must be over 18 years old The duration of the disease is at least one year The patient expresses his / her consent to participate in the study

Exclusion criteria

Exclusion criteria: Having any of the diseases of diabetes, hypertension, thyroid disorder and kidney failure Smoking Pregnancy and lactation Taking supplements (omega 3, antioxidants, etc.) in the last three months Taking contraceptives Changes in the amount of medication taken in the past month

Design outcomes

Primary

MeasureTime frame
High-Sensitivity C-Reactive Protein (hs-CRP). Timepoint: Beginning and end of the study. Method of measurement: enzyme-linked immunosorbent assay(ELISA).;Tumour necrosis factor- a(TNF-a). Timepoint: Beginning and end of the study. Method of measurement: enzyme-linked immunosorbent assay(ELISA).;Total antioxidant capacity (TAC). Timepoint: Beginning and end of the study. Method of measurement: chromatography.;Erythrocyte sedimentation rate(ESR). Timepoint: Beginning and end of the study. Method of measurement: Vacuum tube erythrocyte sedimentation rate.;Superoxide dismutase(SOD). Timepoint: Beginning and end of the study. Method of measurement: Spectrophotometry.;Tender joint counts(TJC). Timepoint: Beginning and end of the study. Method of measurement: doctor checkup.;Swollen joint count. Timepoint: Beginning and end of the study. Method of measurement: doctor checkup.;Illness severity. Timepoint: Beginning and end of the study. Method of measurement: physician global assessment.;Pain. Timepoint: Beginning and end of the study. Method of measurement: visual analogue scale.;Disease activity score. Timepoint: Beginning and end of the study. Method of measurement: Formula DAS28.;Morning stiffness. Timepoint: Beginning and end of the study. Method of measurement: How long (minutes) it takes for the joint dryness to go away.

Secondary

MeasureTime frame
Dosage of non-steroidal anti-inflammatory drugs. Timepoint: Beginning and end of the study. Method of measurement: questionnaire.;BMI. Timepoint: before intervention AND 3 months after intervention. Method of measurement: formula.;Weight. Timepoint: before intervention AND 3 months after intervention. Method of measurement: scales.;Micronutrients and Macronutrients intake. Timepoint: before intervention AND 3 months after intervention. Method of measurement: 24 hour recall questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNaheed Aryaeian

Iran University of Medical Sciences

aryaeian@razi.tums.ac.ir+98 21 8670 4755

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026